Enroll-HD
Clinical Research
A collaboration between Huntington’s disease families, clinicians, and researchers to accelerate progress toward effective treatments.
Current Participants
Your information is powerful! Learn about current research opportunities.
Enroll-HD
Clinical research platform
Enroll-HD is a clinical research platform and the world’s largest observational study for Huntington’s disease families. It is a resource for the entire HD community, including families, clinicians, researchers, advocates, and anyone else who has a connection to or an interest in HD.
A platform for the whole HD community.
Current Participants
Clinical Sites Worldwide
Nations Participating
Enroll-HD: October 16, 2024 data cut
Contact us for trial support
Send us a message. An Enroll-HD team member will get back to you as soon as possible.
Enroll-HD
News
Moving into the Fast Lane: uniQure and the FDA Are on the Same Track for Accelerated Approval
On December 10, 2024 we...
Interim update from Vico Therapeutics on their CAG-targeting drug, VO659
Vico Therapeutics recently presented at...
Going boldly: First person treated in Phase 1 clinical trial by Alnylam Pharmaceuticals
On December 3, 2024 we...
Giving Thanks to the Huntington’s Disease Family Community for Advancing Research
In the spirit of gratitude,...
EHDN & Enroll-HD Strasbourg 2024 | Sep 12-14
EHDN & Enroll-HD Strasbourg 2024 | Sep 12-14 EHDN &...
EN 
ES 
IT 
DE 
FR